Association Between Gait Speed With Mortality, Cardiovascular Disease and Cancer: A Systematic Review and Meta-analysis of Prospective Cohort Studies

Nicola Veronese, Brendon Stubbs, Stefano Volpato, Giovanni Zuliani, Stefania Maggi, Matteo Cesari, Darren M. Lipnicki, Lee Smith, Patricia Schofield, Joseph Firth, Davy Vancampfort, Ai Koyanagi, Alberto Pilotto, Emanuele Cereda

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objectives: Slow gait speed may be associated with premature mortality, cardiovascular disease (CVD), and cancer, although a comprehensive meta-analysis is lacking. In this systematic review and meta-analysis, we explored potential associations between gait speed and mortality, incident CVD, and cancer. Design: A systematic search in major databases was undertaken from inception until March 15, 2018 for prospective cohort studies reporting data on gait speed and mortality, incident CVD, and cancer. Setting and Participants: All available. Measures: The adjusted hazard ratios (HRs) and 95% confidence intervals (CIs), based on the model with the maximum number of covariates for each study between gait speed (categorized as decrease in 0.1 m/s) and mortality, incident CVD, and cancer, were meta-analyzed with a random effects model. Results: Among 7026 articles, 44 articles corresponding to 48 independent cohorts were eligible. The studies followed up on a total of 101,945 participants (mean age 72.2 years; 55% women) for a median of 5.4 years. After adjusting for a median of 9 potential confounders and the presence of publication bias, each reduction of 0.1 m/s in gait speed was associated with a 14% increased risk of earlier mortality (45 studies; HR = 1.12, 95% CI: 1.09-1.14; I2 = 90%) and 8% increased risk of CVD (13 studies; HR = 1.08, 95% CI: 1.03-1.13; I2 = 81%), but no relationship with cancer was observed (HR = 1.00, 95% CI: 0.97-1.04; I2 = 15%). Conclusion/implications: Slow gait speed may be a predictor of mortality and CVD in older adults. Because gait speed is a quick and inexpensive measure to obtain, our study suggests that it should be routinely used and may help identify people at risk of premature mortality and CVD.

Original languageEnglish
Pages (from-to)981-988.e7
JournalJournal of the American Medical Directors Association
Volume19
Issue number11
DOIs
Publication statusPublished - 2018

Fingerprint

Meta-Analysis
Cohort Studies
Cardiovascular Diseases
Prospective Studies
Mortality
Neoplasms
Confidence Intervals
Premature Mortality
Publication Bias
Walking Speed
Research Design
Databases

Keywords

  • cancer
  • cardiovascular disease
  • Gait speed
  • meta-analysis
  • mortality

ASJC Scopus subject areas

  • Nursing(all)
  • Health Policy

Cite this

Association Between Gait Speed With Mortality, Cardiovascular Disease and Cancer : A Systematic Review and Meta-analysis of Prospective Cohort Studies. / Veronese, Nicola; Stubbs, Brendon; Volpato, Stefano; Zuliani, Giovanni; Maggi, Stefania; Cesari, Matteo; Lipnicki, Darren M.; Smith, Lee; Schofield, Patricia; Firth, Joseph; Vancampfort, Davy; Koyanagi, Ai; Pilotto, Alberto; Cereda, Emanuele.

In: Journal of the American Medical Directors Association, Vol. 19, No. 11, 2018, p. 981-988.e7.

Research output: Contribution to journalArticle

Veronese, Nicola ; Stubbs, Brendon ; Volpato, Stefano ; Zuliani, Giovanni ; Maggi, Stefania ; Cesari, Matteo ; Lipnicki, Darren M. ; Smith, Lee ; Schofield, Patricia ; Firth, Joseph ; Vancampfort, Davy ; Koyanagi, Ai ; Pilotto, Alberto ; Cereda, Emanuele. / Association Between Gait Speed With Mortality, Cardiovascular Disease and Cancer : A Systematic Review and Meta-analysis of Prospective Cohort Studies. In: Journal of the American Medical Directors Association. 2018 ; Vol. 19, No. 11. pp. 981-988.e7.
@article{3fe1b674294f4f7383b3592bb818efc3,
title = "Association Between Gait Speed With Mortality, Cardiovascular Disease and Cancer: A Systematic Review and Meta-analysis of Prospective Cohort Studies",
abstract = "Objectives: Slow gait speed may be associated with premature mortality, cardiovascular disease (CVD), and cancer, although a comprehensive meta-analysis is lacking. In this systematic review and meta-analysis, we explored potential associations between gait speed and mortality, incident CVD, and cancer. Design: A systematic search in major databases was undertaken from inception until March 15, 2018 for prospective cohort studies reporting data on gait speed and mortality, incident CVD, and cancer. Setting and Participants: All available. Measures: The adjusted hazard ratios (HRs) and 95{\%} confidence intervals (CIs), based on the model with the maximum number of covariates for each study between gait speed (categorized as decrease in 0.1 m/s) and mortality, incident CVD, and cancer, were meta-analyzed with a random effects model. Results: Among 7026 articles, 44 articles corresponding to 48 independent cohorts were eligible. The studies followed up on a total of 101,945 participants (mean age 72.2 years; 55{\%} women) for a median of 5.4 years. After adjusting for a median of 9 potential confounders and the presence of publication bias, each reduction of 0.1 m/s in gait speed was associated with a 14{\%} increased risk of earlier mortality (45 studies; HR = 1.12, 95{\%} CI: 1.09-1.14; I2 = 90{\%}) and 8{\%} increased risk of CVD (13 studies; HR = 1.08, 95{\%} CI: 1.03-1.13; I2 = 81{\%}), but no relationship with cancer was observed (HR = 1.00, 95{\%} CI: 0.97-1.04; I2 = 15{\%}). Conclusion/implications: Slow gait speed may be a predictor of mortality and CVD in older adults. Because gait speed is a quick and inexpensive measure to obtain, our study suggests that it should be routinely used and may help identify people at risk of premature mortality and CVD.",
keywords = "cancer, cardiovascular disease, Gait speed, meta-analysis, mortality",
author = "Nicola Veronese and Brendon Stubbs and Stefano Volpato and Giovanni Zuliani and Stefania Maggi and Matteo Cesari and Lipnicki, {Darren M.} and Lee Smith and Patricia Schofield and Joseph Firth and Davy Vancampfort and Ai Koyanagi and Alberto Pilotto and Emanuele Cereda",
year = "2018",
doi = "10.1016/j.jamda.2018.06.007",
language = "English",
volume = "19",
pages = "981--988.e7",
journal = "Journal of the American Medical Directors Association",
issn = "1525-8610",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Association Between Gait Speed With Mortality, Cardiovascular Disease and Cancer

T2 - A Systematic Review and Meta-analysis of Prospective Cohort Studies

AU - Veronese, Nicola

AU - Stubbs, Brendon

AU - Volpato, Stefano

AU - Zuliani, Giovanni

AU - Maggi, Stefania

AU - Cesari, Matteo

AU - Lipnicki, Darren M.

AU - Smith, Lee

AU - Schofield, Patricia

AU - Firth, Joseph

AU - Vancampfort, Davy

AU - Koyanagi, Ai

AU - Pilotto, Alberto

AU - Cereda, Emanuele

PY - 2018

Y1 - 2018

N2 - Objectives: Slow gait speed may be associated with premature mortality, cardiovascular disease (CVD), and cancer, although a comprehensive meta-analysis is lacking. In this systematic review and meta-analysis, we explored potential associations between gait speed and mortality, incident CVD, and cancer. Design: A systematic search in major databases was undertaken from inception until March 15, 2018 for prospective cohort studies reporting data on gait speed and mortality, incident CVD, and cancer. Setting and Participants: All available. Measures: The adjusted hazard ratios (HRs) and 95% confidence intervals (CIs), based on the model with the maximum number of covariates for each study between gait speed (categorized as decrease in 0.1 m/s) and mortality, incident CVD, and cancer, were meta-analyzed with a random effects model. Results: Among 7026 articles, 44 articles corresponding to 48 independent cohorts were eligible. The studies followed up on a total of 101,945 participants (mean age 72.2 years; 55% women) for a median of 5.4 years. After adjusting for a median of 9 potential confounders and the presence of publication bias, each reduction of 0.1 m/s in gait speed was associated with a 14% increased risk of earlier mortality (45 studies; HR = 1.12, 95% CI: 1.09-1.14; I2 = 90%) and 8% increased risk of CVD (13 studies; HR = 1.08, 95% CI: 1.03-1.13; I2 = 81%), but no relationship with cancer was observed (HR = 1.00, 95% CI: 0.97-1.04; I2 = 15%). Conclusion/implications: Slow gait speed may be a predictor of mortality and CVD in older adults. Because gait speed is a quick and inexpensive measure to obtain, our study suggests that it should be routinely used and may help identify people at risk of premature mortality and CVD.

AB - Objectives: Slow gait speed may be associated with premature mortality, cardiovascular disease (CVD), and cancer, although a comprehensive meta-analysis is lacking. In this systematic review and meta-analysis, we explored potential associations between gait speed and mortality, incident CVD, and cancer. Design: A systematic search in major databases was undertaken from inception until March 15, 2018 for prospective cohort studies reporting data on gait speed and mortality, incident CVD, and cancer. Setting and Participants: All available. Measures: The adjusted hazard ratios (HRs) and 95% confidence intervals (CIs), based on the model with the maximum number of covariates for each study between gait speed (categorized as decrease in 0.1 m/s) and mortality, incident CVD, and cancer, were meta-analyzed with a random effects model. Results: Among 7026 articles, 44 articles corresponding to 48 independent cohorts were eligible. The studies followed up on a total of 101,945 participants (mean age 72.2 years; 55% women) for a median of 5.4 years. After adjusting for a median of 9 potential confounders and the presence of publication bias, each reduction of 0.1 m/s in gait speed was associated with a 14% increased risk of earlier mortality (45 studies; HR = 1.12, 95% CI: 1.09-1.14; I2 = 90%) and 8% increased risk of CVD (13 studies; HR = 1.08, 95% CI: 1.03-1.13; I2 = 81%), but no relationship with cancer was observed (HR = 1.00, 95% CI: 0.97-1.04; I2 = 15%). Conclusion/implications: Slow gait speed may be a predictor of mortality and CVD in older adults. Because gait speed is a quick and inexpensive measure to obtain, our study suggests that it should be routinely used and may help identify people at risk of premature mortality and CVD.

KW - cancer

KW - cardiovascular disease

KW - Gait speed

KW - meta-analysis

KW - mortality

UR - http://www.scopus.com/inward/record.url?scp=85050356949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050356949&partnerID=8YFLogxK

U2 - 10.1016/j.jamda.2018.06.007

DO - 10.1016/j.jamda.2018.06.007

M3 - Article

AN - SCOPUS:85050356949

VL - 19

SP - 981-988.e7

JO - Journal of the American Medical Directors Association

JF - Journal of the American Medical Directors Association

SN - 1525-8610

IS - 11

ER -